What federal law protects the confidentiality of substance use disorder treatment records?

The protection of confidentiality for substance use disorder treatment records is governed by 42 CFR Part 2. This federal regulation specifically addresses the privacy of individuals receiving substance use disorder treatment and ensures that their medical records cannot be disclosed without their consent. These provisions are particularly important given the stigma associated with substance use disorders and the potential repercussions individuals may face if their treatment history is disclosed.

42 CFR Part 2 places strict restrictions on how and when information regarding substance use can be shared, requiring that patient consent is obtained prior to any disclosure. This regulation is crucial in fostering a safe environment where individuals can seek treatment without fear of judgment or repercussions.

In contrast, HIPAA provides a broader scope of privacy protections for various health information, but it does not offer the same specific and stringent protections for substance use disorder treatment records as 42 CFR Part 2. FERPA pertains to educational records and is not applicable in this context, while the ADA focuses on the rights of individuals with disabilities rather than the confidentiality of health records. Thus, 42 CFR Part 2 is the correct answer, as it is specifically designed to protect the confidentiality of substance use disorder treatment records.